Interaction of KATP channels and endothelin-1 in lambs with persistent pulmonary hypertension of the newborn

Pediatric Research

Volumn 60, Issue 3, 2006, Pages 252-257

  Maurey, Christelle ^a   Hislop, Alison A ^b   Advenier, Charles ^a   Vouhé, Pascal R ^c   Israël Biet, Dominique ^a   Lévy, Marilyne ^a,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; NITRIC OXIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL KIR 6.1; POTASSIUM CHANNEL STIMULATING AGENT; SR 47063; UNCLASSIFIED DRUG; ENDOTHELIN 1; MITOCHONDRIAL K(ATP) CHANNEL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DUCTUS ARTERIOSUS OBLITERATION; IMMUNOHISTOCHEMISTRY; LAMB; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; WESTERN BLOTTING; ANIMAL; CONGENITAL MALFORMATION; DISEASE MODEL; HEART VENTRICLE; HUMAN; METABOLISM; PERSISTENT FETUS CIRCULATION; SHEEP;

ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; HEART VENTRICLES; HUMANS; INFANT, NEWBORN; PERSISTENT FETAL CIRCULATION SYNDROME; POTASSIUM CHANNELS; SHEEP;

EID: 33747605054     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000233075.48306.57     Document Type: Article

References (34)

1. Haworth SG, Reid L 1976 Persistent fetal circulation: newly recognized structural features. J Pediatr 88:614-20
2. Kinsella JP, Abman SH 1995 Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 126:853-864
3. Dakshinamurti S 2005 Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn. Pediatr Pulmonol 39:492-503
4. Wojciak-Stothard B, Haworth SG 2006 Perinatal changes in pulmonary vascular endothelial function. Pharmacol Ther 109:78-91
5. La M, Reid JJ 1995 Endothelin-1 and the regulation of vascular tone. Clin Exp Pharmacol Physiol 22:315-323
6. Hay DW, Luttmann MA, Muccitelli RM, Goldie RG 1999 Endothelin receptors and calcium translocation pathways in human airways. Naunyn Schmiedebergs Arch Pharmacol 359:404-410
7. Ivy DD, Lee DS, Rairigh RL, Parker TA, Abman SH 2004 Endothelin B receptor blockade attenuates pulmonary vasodilation in oxygen-ventilated fetal lambs. Biol Neonate 86:155-159
8. Levy M, Tulloh RM, Komai H, Stuart-Smith K, Haworth SG 1995 Maturation of the contractile response and its endothelial modulation in newborn porcine intrapulmonary arteries. Pediatr Res 38:25-29
9. Shekerdemian LS, Penny DJ, Ryhammer PK, Reader JA, Ravn HB 2004 Endothelin-A receptor blockade and inhaled nitric oxide in a porcine model of meconium aspiration syndrome. Pediatr Res 56:353-358
10. Endo A, Ayusawa M, Minato M, Takada M, Takahashi S, Harada K 2001 Endogenous nitric oxide and endothelin-1 in persistent pulmonary hypertension of the newborn. Eur J Pediatr 160:217-222
11. Villamor E, Le Cras, TD Horan MP, Halbower AC, Tuder RM, Abman SH 1997 Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus. Am J Physiol 272:L1013-L1020
12. Murata T, Sato K, Hori M, Ozaki H, Karaki H 2002 Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. J Biol Chem 277:44085-44092
13. Pierce CM, Krywawych S, Petros AJ 2004 Asymmetric dimethyl arginine and symmetric dimethyl arginine levels in infants with persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 5:517-520
14. Ichiba H, Matsunami S, Itoh F, Ueda T, Ohsasa Y, Yamano T 2003 Three-year follow up of term and near-term infants treated with inhaled nitric oxide. Pediatr Int 45:290-293
15. Gosche JR 2001 Oxygen dilation in fetal pulmonary arterioles: role of K(+) channels. J Surg Res 97:159-163
16. Cornfield DN, Resnik ER, Herron JM, Reinhartz O, Fineman JR 2002 Pulmonary vascular K+ channel expression and vasoreactivity in a model of congenital heart disease. Am J Physiol Lung Cell Mol Physiol 283:L1210-L1219
17. Olschewski A, Hong Z, Linden BC, Porter VA, Weir EK, Cornfield DN 2002 Contribution of the K(Ca) channel to membrane potential and O2 sensitivity is decreased in an ovine PPHN model. Am J Physiol Lung Cell Mol Physiol 283:L1103-L1109
18. Levy M, Souil E, Sabry S, Favatier F, Vaugelade P, Mercier JC, Dall'Ava-Santucci J, Dinh-Xuan AT 2000 Maturational changes of endothelial vasoactive factors and pulmonary vascular tone at birth. Eur Respir J 15:158-165
19. Levy M, Maurey C, Dinh-Xuan AT, Vouhe P, Israel-Biet D 2005 Developmental expression of vasoactive and growth factors in human lung. Role in pulmonary vascular resistance adaptation at birth. Pediatr Res 57:21R-25R
20. Goirand F, Bardou M, Guerard P, Dumas JP, Rochette L, Dumas M 2003 ET-A, mixed ET-A/ET-B receptor antagonists, and protein kinase C inhibitor prevent acute hypoxic pulmonary vasoconstriction: influence of potassium channels. J Cardiovasc Pharmacol 41:117-125
21. Sato K, Morio Y, Morris KG, Rodman DM, McMurtry IF 2000 Mechanism of hypoxic pulmonary vasoconstriction involves ET(A) receptor-mediated inhibition of K(ATP) channel. Am J Physiol Lung Cell Mol Physiol 278:L434-L442
22. ATP channels in rabbit coronary and pulmonary arterial smooth muscle cells. J Cardiovasc Pharmacol 45:99-108
23. Morin FC3rd 1989 Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr Res 25:245-250
24. Villamor E, Le Cras, TD Horan MP, Halbower AC, Tuder RM, Abman SH 1997 Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus. Am J Physiol 272:L1013-L1020
25. ATP and a time-dependent current likely due to potassium accumulation. J Membr Biol 142:337-347
26. Theis JG, Liu Y, Coceani F 1997 ATP-gated potassium channel activity of pulmonary resistance vessels in the lamb. Can J Physiol Pharmacol 75:1241-1248
27. Cornfield DN, McQueston JA, McMurtry IF, Rodman DM, Abman SH 1992 Role of ATP-sensitive potassium channels in ovine fetal pulmonary vascular tone. Am J Physiol 263:H1363-H1368
28. Pinheiro JM, Malik AB 1992 KATP-channel activation causes marked vasodilation in the hypertensive neonatal pig lung. Am J Physiol 263:H1532-H1536
29. Boels PJ, Gao B, Deutsch J, Haworth SG 1997 ATP-dependent K+ channel activation in isolated normal and hypertensive newborn and adult porcine pulmonary vessels. Pediatr Res 42:317-326
30. Oishi P, Grobe A, Benavidez E, Ovadia B, Harmon C, Ross GA, Hendricks-Munoz K, Xu J, Black SM, Fineman JR 2006 Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension: A role for superoxide and peroxynitrite in the intact lamb. Am J Physiol Lung Cell Mol Physiol 290:L359-L366
31. Steinhorn RH, Albert G, Swartz DD, Russell JA, Levine CR, Davis JM 2001 Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension. Am J Respir Crit Care Med 164:834-839
32. Armstead WM 1999 Superoxide generation links protein kinase C activation to impaired ATP-sensitive K+ channel function after brain injury. Stroke 30:153-159
33. Kasemsri T, Armstead WM 1997 Endothelin impairs ATP-sensitive K+ channel function after brain injury. Am J Physiol 273:H2639-H2647
34. Maiya S, Hislop AA, Flynn Y, Haworth SG 2006 Response to bosentan in children with pulmonary hypertension. Heart 92:664-670